SwePub
Sök i LIBRIS databas

  Utökad sökning

L773:1872 7913
 

Sökning: L773:1872 7913 > Naturally occurring...

Naturally occurring dipeptide from elite controllers with dual anti-HIV-1 mechanism

Cena-Diez, Rafael (författare)
Karolinska Institutet
Narayanan, Aswathy (författare)
Karolinska Inst, Dept Med Huddinge, Div Infect Dis, ANA Futura Lab, Stockholm, Sweden.
Ray, Shilpa (författare)
Karolinska Institutet
visa fler...
van de Klundert, Maarten (författare)
Karolinska Institutet
Rodriguez, Jimmy E. (författare)
Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 1, Stockholm, Sweden.
Nilvebrant, Johan, 1982- (författare)
KTH,Proteinteknologi
Nygren, Per-Åke, 1961- (författare)
KTH,Proteinteknologi,Science for Life Laboratory, SciLifeLab
Vegvari, Akos (författare)
Karolinska Institutet
van Domselaar, Robert (författare)
Karolinska Institutet
Sonnerborg, Anders (författare)
Karolinska Institutet
visa färre...
Karolinska Institutet Karolinska Inst, Dept Med Huddinge, Div Infect Dis, ANA Futura Lab, Stockholm, Sweden (creator_code:org_t)
Elsevier BV, 2023
2023
Engelska.
Ingår i: International Journal of Antimicrobial Agents. - : Elsevier BV. - 0924-8579 .- 1872-7913. ; 61:5, s. 106792-
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Enhanced levels of a dipeptide, WC-am, have been reported among elite controllers - patients who spontaneously control their HIV-1 infection. This study aimed to evaluate anti-HIV-1 activity and mechanism of action of WC-am.Methods: Drug sensitivity assays in TZM.bl cells, PBMCs and ACH-2 cells using WT and mutated HIV-1 strains were performed to evaluate the antiviral mechanism of WC-am. Mass spectrometry-based proteomics and Real-time PCR analysis of reverse transcription steps were performed to unravel the second anti-HIV-1 mechanism of WC-am.Results: The data suggest that WC-am binds to the CD4 binding pocket of HIV-1 gp120 and blocks its binding to the host cell receptors. Additionally, the time course assay showed that WC-am also inhibited HIV-1 at 4-6 hours post-infection, suggesting a second antiviral mechanism. Drug sensitivity assays under acidic wash conditions confirmed the ability of WC-am to internalise into the host cell in an HIV independent manner. Proteomic studies showed a clustering of all samples treated with WC-am independent of the number of doses or presence or absence of HIV-1. Differentially expressed proteins due to the WC-am treatment indicated an effect on HIV-1 reverse transcription, which was confirmed by reverse transcriptase polymerase chain reaction (RT-PCR).Conclusion: Naturally occurring in HIV-1 elite controllers, WC-am stands out as a new kind of antiviral compound with two independent inhibitory mechanisms of action on HIV-1 replication. WC-am halts HIV-1 entry to the host cell by binding to HIV-1 gp120, thereby blocking the binding of HIV-1 to the host cell. WC-am also exerts a post-entry but pre-integration antiviral effect related to RT-activity.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Infectious Medicine (hsv//eng)

Nyckelord

Antiviral
HIV
Dual mechanism
Entry
Retrotranscription
Therapy

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy